Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 14Colorectal Neoplasms 9Neoplasm Metastasis 3Leukemia, Myeloid, Acute 3Sarcoma, Ewing 2Rectal Neoplasms 2Myelodysplastic Syndromes 2Liver Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Wilms Tumor 1Thrombocytosis 1Solid Tumor 1Small Cell Lung Carcinoma 1Rhabdomyosarcoma 1Renal Insufficiency 1Prostatic Neoplasms 1Primary Myelofibrosis 1Pretreated Metastatic Colorectal Cancer 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neuroblastoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Metastatic Solid Malignancies 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

pembrolizumab 10Docetaxel 8senaparib 7Injections 7Capecitabine 7Paclitaxel 6Cisplatin 6Irinotecan 5Fluorouracil 5Leucovorin 4Cyclophosphamide 4Bevacizumab 4tislelizumab 3pertuzumab 3fludarabine 3atezolizumab 3Rifampin 3Oxaliplatin 3Itraconazole 3Gemcitabine 3ontuxizumab 2navoximod 2fluzoparib 2durvalumab 2Trastuzumab 2Nivolumab 2Midazolam 2Hydroxychloroquine 2Carboplatin 2130-nm albumin-bound paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Solid Tumor × regorafenib × Clear all
NCT02466802 2020-02-20

Study of Regorafenib and Sildenafil for Advanced Solid Tumors

Virginia Commonwealth University

Phase 1 Completed
32 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡